Table 3 Multivariate Cox proportional hazard regression analysis of RFS for patients with BRCA
From: Comprehensive analysis of suppressor of cytokine signaling proteins in human breast Cancer
Variates | HR | 95% CI | P value |
|---|---|---|---|
SOCS2 | |||
 Low | Reference |  |  |
 High | 0.680 | 0.487–1.095 | 0.034 |
SOCS3 | |||
 Low | Reference |  |  |
 High | 0.954 | 0.553–1.644 | 0.865 |
SOCS4 | |||
 Low | Reference |  |  |
 High | 0.898 | 0.508–1.587 | 0.469 |
SOCS5 | |||
 Low | Reference |  |  |
 High | 1.296 | 0.750–2.240 | 0.153 |
Age | 0.979 | 0.959–1.001 | 0.056 |
AJCC Stage |  |  | < 0.001 |
 I | Reference |  |  |
 II | 1.311 | 0.567–3.031 | 0.526 |
 III | 3.444 | 1.456–8.147 | 0.005 |
 IV | 70.265 | 7.471 | 660.835 |